Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,416,422
  • Shares Outstanding, K 85,325
  • Annual Sales, $ 1,472 M
  • Annual Income, $ 60,800 K
  • 60-Month Beta 0.96
  • Price/Sales 2.96
  • Price/Cash Flow 13.59
  • Price/Book 3.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.61
  • Number of Estimates 8
  • High Estimate 0.63
  • Low Estimate 0.59
  • Prior Year 0.58
  • Growth Rate Est. (year over year) +5.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.69 +6.69%
on 04/18/19
56.29 -5.81%
on 04/01/19
-2.27 (-4.11%)
since 03/22/19
3-Month
45.07 +17.64%
on 01/24/19
57.62 -7.98%
on 03/21/19
+7.16 (+15.61%)
since 01/23/19
52-Week
42.14 +25.82%
on 01/03/19
67.50 -21.45%
on 06/18/18
-2.70 (-4.85%)
since 04/23/18

Most Recent Stories

More News
Biotech Brief: Optimistic Outlook Growing for Multi-billion Dollar Medical Device Industry

A recent industry article reported on an optimistic overview concerning the Medical Device Industry. It said: "The medical device industry should see a stand-out year in 2019, according to a Moody's report...

MHMNF : 54.5000 (unch)
IART : 53.02 (+2.43%)
BAX : 76.34 (+1.45%)
SOLY : 13.72 (+11.64%)
MBRX : 1.59 (-46.64%)
MBIO : 6.05 (-3.66%)
Integra LifeSciences Introduces New Codman Specialty Surgical Products at AANS 2019

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it will feature its latest innovations at the American Association of Neurological...

IART : 53.02 (+2.43%)
Integra LifeSciences to Host First Quarter 2019 Earnings Results Conference Call on April 24, 2019

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2019 financial results on Wednesday, April 24, 2019, prior to market open....

IART : 53.02 (+2.43%)
Top 5 Companies in the Health Care Equipment Industry with the Best Relative Performance (MASI , IDXX , IART , PODD , EW )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

IART : 53.02 (+2.43%)
IDXX : 224.45 (+1.29%)
MASI : 127.09 (+2.84%)
Integra's Product Launch a Growth Catalyst, Rivalry Rife

Product launches and a sales force performance upgrade are likely to boost rapid organic growth for Integra LifeSciences (IART) in the second half of 2019.

SYK : 186.96 (+2.64%)
VAR : 132.91 (+1.87%)
PEN : 130.85 (+0.72%)
IART : 53.02 (+2.43%)
Research Report Identifies LGI Homes, Under Armour, Frontline, Alliance Resource Partners, CF Industries, and Integra LifeSciences with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of LGI Homes, Inc. (NASDAQ:LGIH), Under...

FRO : 8.02 (-1.47%)
CF : 44.57 (-0.85%)
UAA : 22.38 (+2.01%)
IART : 53.02 (+2.43%)
LGIH : 70.15 (+3.00%)
ARLP : 18.92 (+0.37%)
Why Is Integra (IART) Down 0.5% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IART : 53.02 (+2.43%)
Shares of IART Up 15.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Integra Lifescie (NASDAQ:IART) on February 5th, 2019 at $48.50. In approximately 2 month, Integra Lifescie has returned 15.26% as of today's recent price of $55.90....

IART : 53.02 (+2.43%)
Glaukos Corp has the Best Relative Performance in the Health Care Equipment Industry (GKOS , IART , DHR , ABT , PODD )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

IART : 53.02 (+2.43%)
GKOS : 71.63 (+1.73%)
DHR : 127.78 (+0.72%)
Integra's Duragen Secures Japanese Nod to Drive Global Growth

Despite facing adverse foreign exchange volatility across its international business, Integra LifeSciences (IART) can successfully eye certain key developments on foreign shores.

ABMD : 262.18 (+0.48%)
PEN : 130.85 (+0.72%)
IART : 53.02 (+2.43%)
MASI : 127.09 (+2.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade IART with:

Business Summary

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic...

See More

Key Turning Points

2nd Resistance Point 55.03
1st Resistance Point 54.02
Last Price 53.02
1st Support Level 51.76
2nd Support Level 50.51

See More

52-Week High 67.50
Fibonacci 61.8% 57.81
Fibonacci 50% 54.82
Last Price 53.02
Fibonacci 38.2% 51.83
52-Week Low 42.14

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar